Leuconostoc pseudomesenteroides

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Leuconostoc pseudomesenteroides is a Gram-positive, non-spore-forming, facultatively anaerobic, non-motile, coccus bacterium. It has been detected in at least 3 gut microbiome compilation studies or metastudies. The DNA G+C content is 38.1-40.8%. Leuconostoc pseudomesenteroides is likely to be transient and not a long-term gut coloniser. (Farrow1989)



  • This organism has been recovered from human faeces (Bilen2018e), clinical sources (blood, human joint) and a starter. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread (notes: opportunistic in immunocompromised patients). Is a rare opportunistic pathogen. Likely to be transient and not a long-term gut commensal.
    • GENERAL CHARACTERISTICS (Farrow1989);
    Character Response
  • 🌡
  • Temperature tolerance:
  • grows at 10℃; grows at 37℃;
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; fructose; galactose; glucose; mannose; ribose; xylose; cellubiose; lactose; maltose; melibiose; raffinose; sucrose; trehalose; D-turanose; α-methyl glucoside; N-Ac glucosamine;
  • ±
  • Strain-dependent acid from carbs:
  • amygdalin; aesculin; gentiobiose; arbutin; gluconate; 2-ketogluconate; 5-ketogluconate; salicin;
    • RESPONSE TO ANTIBIOTICS (Farrow1989);
    Class Active Resistant
  • Vancomycins:
  • vancomycin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Firmicutes Class:  Bacilli Order:  Lactobacillales Family:  Lactobacillaceae Genus:  Leuconostoc Gram stain:  + O2 Relation.:  facultatively anaerobic Spore:  No spore Motility:  Sessile Morphology:  Coccus
    Health:  Unknown
    Source:  human faeces (Bilen2018e), clinical sources (blood, human joint) and a starter
    DNA G+C(%):  38.1-40.8
    Low T(℃):  10(+)
    Mid T(℃):  37(+)
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    D-Arabinose:  neg L-Arabinose:  d(+) Fructose:  + Fucose:  neg D-Fucose:  neg Galactose:  d(+) Glucose:  + Mannose:  + D-Lyxose:  neg Rhamnose:  neg Ribose:  + Sorbose:  neg D-Tagatose:  neg Xylose:  + L-Xylose:  neg Cellubiose:  d(+) Gentiobiose:  d Lactose:  d(+) Maltose:  + Melezitose:  neg Melibiose:  + Sucrose:  d(+) Trehalose:  + Turanose:  d(+) Amygdalin:  d(neg) Aesculin:  d Inulin:  neg Adonitol:  neg D-Arabitol:  neg L-Arabitol:  neg Dulcitol:  neg Erythritol:  neg Glycerol:  neg Inositol:  neg Mannitol:  neg Sorbitol:  neg Xylitol:  neg Arbutin:  d(neg) Gluconate:  d 2-Ketogluconate:  d(neg) 5-Ketogluconate:  d(neg) Me-α-D-Glc:  + Me-α-D-Mann:  neg NAc-α-GA:  + Salicin:  d
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    vancomycin:  Res

    References

    SPECIFIC REFERENCES FOR LEUCONOSTOC PSEUDOMESENTEROIDES
  • Farrow1989 - Nucleic Acid Homologies of Some Vancomycin-Resistant Leuconostocs and Description of Leuconostoc citreum sp. nov. and Leuconostoc pseudomesenteroides sp. nov.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR LEUCONOSTOC PSEUDOMESENTEROIDES
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • Forster2019 - A human gut bacterial genome and culture collection for improved metagenomic analyses.
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................
    • GENERAL REFERENCES FOR LEUCONOSTOC PSEUDOMESENTEROIDES
  • Bilen2018e - Description of the human gut microbiota by culturomics
    • Added: December 15, 2021